• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cancer stem cells in head and neck cancer.头颈癌中的癌症干细胞。
Am J Stem Cells. 2021 Aug 15;10(3):28-35. eCollection 2021.
2
Targeting cancer stem cells in squamous cell carcinoma.靶向鳞状细胞癌中的癌症干细胞。
Precis Clin Med. 2019 Sep;2(3):152-165. doi: 10.1093/pcmedi/pbz016. Epub 2019 Oct 1.
3
Oral Cancer Stem Cells: Therapeutic Implications and Challenges.口腔癌干细胞:治疗意义与挑战
Front Oral Health. 2021 Jul 21;2:685236. doi: 10.3389/froh.2021.685236. eCollection 2021.
4
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中与放射抗性相关的癌症干细胞标志物
Oncotarget. 2015 Oct 27;6(33):34494-509. doi: 10.18632/oncotarget.5417.
5
Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.头颈部鳞状细胞癌干细胞中的独特表观遗传学特征。
Otolaryngol Head Neck Surg. 2011 Jun;144(6):900-9. doi: 10.1177/0194599811398786. Epub 2011 Feb 18.
6
Biology and immunology of cancer stem(-like) cells in head and neck cancer.头颈癌中癌症干细胞(样)的生物学与免疫学
Crit Rev Oncol Hematol. 2015 Sep;95(3):337-45. doi: 10.1016/j.critrevonc.2015.03.009. Epub 2015 Apr 9.
7
Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.基质透明质酸上调组蛋白甲基转移酶DOT1L可促进微小RNA-10表达,导致头颈部鳞状细胞癌癌症干细胞的肿瘤细胞侵袭和化疗耐药。
J Biol Chem. 2016 May 13;291(20):10571-85. doi: 10.1074/jbc.M115.700021. Epub 2016 Mar 21.
8
Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.对头颈部鳞状细胞癌中具有干细胞特性的癌细胞进行鉴定、扩增及特性分析。
Exp Cell Res. 2016 Oct 15;348(1):75-86. doi: 10.1016/j.yexcr.2016.09.003. Epub 2016 Sep 9.
9
Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.癌症干细胞的当前认识:其放射生物学及在头颈癌中作用的综述
Head Neck. 2017 Sep;39(9):1920-1932. doi: 10.1002/hed.24848. Epub 2017 Jun 23.
10
cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.载顺铂纳米药物上 cRGD 肽的安装增强了对具有癌症干细胞样细胞的局部晚期头颈部鳞状细胞癌的疗效。
J Control Release. 2017 Sep 10;261:275-286. doi: 10.1016/j.jconrel.2017.06.021. Epub 2017 Jun 27.

引用本文的文献

1
The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma.Hedgehog 信号通路在头颈部鳞状细胞癌中的作用。
Cells. 2023 Aug 17;12(16):2083. doi: 10.3390/cells12162083.
2
Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis.多组学鉴定头颈部鳞状细胞癌中的遗传改变和 HNC018 作为新型 c-MET/STAT3/AKT 信号轴多靶点药物的治疗效果。
Int J Mol Sci. 2023 Jun 16;24(12):10247. doi: 10.3390/ijms241210247.
3
Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中癌症干细胞基因表达特征与预后的相关性。
BMC Cancer. 2022 Oct 19;22(1):1077. doi: 10.1186/s12885-022-10184-4.
4
Diversity of the Origin of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Its Clinical Implications.口腔鳞状细胞癌中癌干细胞起源的多样性及其临床意义
Cancers (Basel). 2022 Jul 22;14(15):3588. doi: 10.3390/cancers14153588.

本文引用的文献

1
mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.mTOR 抑制消除顺铂耐药唾液腺癌干样细胞。
J Dent Res. 2021 Apr;100(4):377-386. doi: 10.1177/0022034520965141. Epub 2020 Oct 17.
2
Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.CRTC1/3-MAML2 融合对唾液腺黏液表皮样癌预后的影响:一项多机构回顾性研究。
Cancer Sci. 2020 Nov;111(11):4195-4204. doi: 10.1111/cas.14632. Epub 2020 Sep 14.
3
Targeting cancer stem cell pathways for cancer therapy.针对癌症干细胞通路的癌症治疗。
Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5.
4
Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.整合素β1 在头颈部鳞状细胞癌中的干细胞标志物作用。
Oral Oncol. 2019 Sep;96:34-41. doi: 10.1016/j.oraloncology.2019.07.001. Epub 2019 Jul 4.
5
The molecular markers of cancer stem cells in head and neck tumors.头颈部肿瘤中癌症干细胞的分子标志物。
J Cell Physiol. 2020 Jan;235(1):65-73. doi: 10.1002/jcp.28963. Epub 2019 Jun 17.
6
Nasopharyngeal carcinoma.鼻咽癌。
Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6.
7
Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.诱导化疗反应作为指导优化治疗鼻腔鼻窦未分化癌的方法。
J Clin Oncol. 2019 Feb 20;37(6):504-512. doi: 10.1200/JCO.18.00353. Epub 2019 Jan 7.
8
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.通过治疗性抑制黏蛋白样表皮样癌中 MDM2-p53 相互作用来消融癌症干细胞。
Clin Cancer Res. 2019 Mar 1;25(5):1588-1600. doi: 10.1158/1078-0432.CCR-17-2730. Epub 2018 Nov 29.
9
FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma.FoxM1促进鼻咽癌的细胞增殖、侵袭及干细胞特性。
Front Oncol. 2018 Oct 26;8:483. doi: 10.3389/fonc.2018.00483. eCollection 2018.
10
FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.成纤维细胞生长因子受体(FGFR)信号传导调节头颈癌干细胞对顺铂的耐药性。
Oncotarget. 2018 May 18;9(38):25148-25165. doi: 10.18632/oncotarget.25358.

头颈癌中的癌症干细胞。

Cancer stem cells in head and neck cancer.

作者信息

Picon Hector, Guddati Achuta Kumar

机构信息

Medical College of Georgia, Augusta University Augusta 30909, GA, USA.

Division of Hematology/Oncology, Georgia Cancer Center, Augusta University Augusta 30912, GA, USA.

出版信息

Am J Stem Cells. 2021 Aug 15;10(3):28-35. eCollection 2021.

PMID:34552815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8449141/
Abstract

Cancer stem cells (CSCs) are a unique population of cells found within tumors that are able to self-renew, restore the original heterogeneity of a tumor following treatment, and show increased tumorigenic potential when compared to other cancer cells. It is thought that they are responsible for the recurrence of tumors as well as the resistance to treatment that is seen clinically. CSCs are known to be involved in head and neck cancer (HNCs) specifically, as evidence for their existence can be found in head and neck squamous cell carcinoma (HNSCC), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC), among others. Here, findings from various approaches to identifying and targeting CSCs and their downstream effectors in HNC are summarized, with an emphasis on recent advancements. Prognostic and therapeutic markers are discussed for each specific type of HNC, and novel treatment strategies and current clinical trials involving CSCs are detailed as well. The information provided here is intended to further the research on this important topic and lead to clinical impact in the battle against HNC.

摘要

癌症干细胞(CSCs)是肿瘤内发现的一类独特细胞群,它们能够自我更新,在治疗后恢复肿瘤原有的异质性,并且与其他癌细胞相比具有更高的致瘤潜力。人们认为它们是肿瘤复发以及临床上所见治疗抗性的原因。已知CSCs特别涉及头颈癌(HNCs),因为在头颈部鳞状细胞癌(HNSCC)、黏液表皮样癌(MEC)和腺样囊性癌(ACC)等疾病中都能找到它们存在的证据。在此,总结了在HNC中识别和靶向CSCs及其下游效应器的各种方法的研究结果,重点是近期进展。针对每种特定类型的HNC讨论了预后和治疗标志物,还详细介绍了涉及CSCs的新型治疗策略和当前临床试验。此处提供的信息旨在推动对这一重要课题的研究,并在对抗HNC的斗争中产生临床影响。